Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Joby Aviation
JOBY
|
$453M |
| 2 |
Datadog
DDOG
|
$423M |
| 3 |
Cloudflare
NET
|
$378M |
| 4 |
Mercado Libre
MELI
|
$311M |
| 5 |
Amazon
AMZN
|
$290M |
Top Sells
| 1 |
Tesla
TSLA
|
$750M |
| 2 |
Booking.com
BKNG
|
$484M |
| 3 |
Netflix
NFLX
|
$450M |
| 4 |
Spotify
SPOT
|
$372M |
| 5 |
Carvana
CVNA
|
$364M |
Sector Composition
| 1 | Consumer Discretionary | 27.35% |
| 2 | Technology | 24.66% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Vuzix
VUZI
$162M
| – | – |
-924
| Closed | -$3.83K |
|
327
Veritone
VERI
$164M
| – | – |
-649
| Closed | -$3.78K |
|
328
Visteon
VC
$3.35B
| – | – |
-253
| Closed | -$39.7K |
|
329
Vale
VALE
$43.6B
| – | – |
-632
| Closed | -$9.97K |
|
|
EAR
330
DELISTED
Eargo, Inc. Common Stock
EAR
| – | – |
-13
| Closed | -$61 |
|
331
Telus
TU
$25.1B
| – | – |
-576
| Closed | -$11.4K |
|
332
Toro Company
TTC
$7.95B
| – | – |
-292
| Closed | -$32.5K |
|
|
TSVT
333
DELISTED
2seventy bio
TSVT
| – | – |
-286
| Closed | -$2.92K |
|
334
Tractor Supply
TSCO
$31.9B
| – | – |
-177
| Closed | -$41.6K |
|
335
Target
TGT
$42B
| – | – |
-112
| Closed | -$18.6K |
|
336
Skyworks Solutions
SWKS
$10.9B
| – | – |
-136
| Closed | -$16K |
|
337
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-231
| Closed | -$31.8K |
|
338
Snap-on
SNA
$16.8B
| – | – |
-86
| Closed | -$21.2K |
|
339
Sangamo Therapeutics
SGMO
$161M
| – | – |
-2,510
| Closed | -$4.42K |
|
340
Stitch Fix
SFIX
$692M
| – | – |
-34,610
| Closed | -$177K |
|
341
SEI Investments
SEIC
$10.8B
| – | – |
-508
| Closed | -$29.2K |
|
342
Seer Inc
SEER
$114M
| – | – |
-223
| Closed | -$861 |
|
343
Rollins
ROL
$27.3B
| – | – |
-623
| Closed | -$23.4K |
|
344
Rambus
RMBS
$7.93B
| – | – |
-740
| Closed | -$37.9K |
|
345
Robert Half
RHI
$3.78B
| – | – |
-131
| Closed | -$10.6K |
|
346
Regenxbio
RGNX
$498M
| – | – |
-817
| Closed | -$15.4K |
|
347
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-54
| Closed | -$44.4K |
|
348
RB Global
RBA
$21.3B
| – | – |
-1,538,987
| Closed | -$86.6M |
|
349
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-115
| Closed | -$4.61K |
|
350
Q2 Holdings
QTWO
$4.83B
| – | – |
-517,328
| Closed | -$12.7M |
|